About Index Trending news
Analyze
Pricing
TESARO, Inc.

TESARO, Inc.

TESARO, Inc.

TESARO is a biopharmaceutical company devoted to providing transformative therapies to people bravely facing cancer.
I work here Suggest edits
More info

Elsewhere

Companies in the same industry

Entegrion Entegrion Just Biotherapeutics Just Biotherapeutics NanoCellect Biomedical, Inc. NanoCellect Biomedical, Inc. Motus Therapeutics Motus Therapeutics Micell Technologies, Inc. Micell Technologies, Inc. GeneCentric Diagnostics, Inc. GeneCentric Diagnostics, Inc. Silverback Therapeutics Silverback Therapeutics Repare Therapeutics Repare Therapeutics E-Scape Bio E-Scape Bio Palleon Pharmaceuticals Palleon Pharmaceuticals

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
Add round
18 Apr 2016
$50,000,000
Post-IPO equity

SEC FORM D

sec
10 Mar 2016
$155,000,000
Post-IPO equity

SEC FORM D

sec
21 Jun 2011
$101,000,000
Venture capital (Series B)
InterWest Partners, Kleiner Perkins Caufield & Byers, Pappas Ventures, +2
28 May 2010
$60,000,000
Venture capital (Series A)
NEA